These pages use javascript to create fly outs and drop down navigation elements.

HSR&D » Funding » Cdp » Clinician » Cda_awardees
HSR&D Logo
  
Search HSR&D:

Peter J. Kaboli, MD, MS

Peter J. Kaboli, MD, MS
VA Center for Research in the Implementation of Innovative Strategies in Practice
Iowa City, IA



Find citations from this investigator | Find recent studies by this investigator

Peter J. Kaboli, MD, MS, completed medical training at the University of Iowa in 1994, and residency and chief residency in internal medicine at LDS Hospital in Salt Lake City in 1998. He completed a general medicine fellowship and Masters Degree at the University of Iowa in 2000 and VA Quality Scholars Fellowship in 2001. Undergraduate work, at the University of Iowa, was in biology. He joined the Iowa City VA in 1998.

Dr. Kaboli's research has been in the area of medication safety and interventions to improve medication appropriateness, bridging the gap between quality improvement and health services research. He has conducted a randomized trial (IIR-98152-1) of a clinical pharmacist/physician intervention to improve prescribing and outcomes in elderly veterans with polypharmacy and the AHRQ funded "Multi-Center Trial of Academic Hospitalists" (R01 HS10597-01A2). He was recently awarded a VA Merit award "Implementing Evidence-Based Treatment of Hypertension" (IMV 04-066-1)

Dr. Kaboli's RCD award (1/04-12/06) was designed to advance skills in quantitative methods, improve conceptual understanding of organizational behavior and collaborative teams, and develop a program to measure medication appropriateness and test an intervention to improve the effectiveness of medication regimens. A Career Development Transition Award (CDTA) was awarded (1/07-1/08) to further develop a program of incremental research to study the impact of an emerging medical specialty-hospitalists-and gain further insight into organizational factors that may influence the quality and efficiency of care for hospitalized veterans.

A recent publication combining expertise in pharmacy interventions and hospital medicine includes "Clinical Pharmacists and Inpatient Medical Care: A Systematic Review" (Arch Int Med 2006) and from the ongoing VA Merit is "Patient and Provider Perceptions of Hypertension Treatment: Do They Agree?" (J Clin Hypertens 2007).

Dr. Kaboli's RCD mentors are Gary Rosenthal, MD, a leader in assessing provider performance and healthcare re-engineering, and Barry Carter, PharmD, an expert in designing pharmacy interventions and pharmacy-related outcomes measurement. For the CDTA, in addition to Dr. Rosenthal, secondary mentorship is provided by Martin Charns, DBA on organization management practices and quality and Gregory Stewart, PhD in interdisciplinary team structure and performance.